Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The EuroSIDA study: 25 years of scientific achievements

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Compassionate Use of Remdesivir in Covid-19

    Research output: Contribution to journalLetterResearchpeer-review

  2. Interstitial lung abnormalities in people with HIV infection and uninfected controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Remdesivir til behandling af COVID-19-pneumoni

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Jens Lundgren
  • Abdel Babiker
  • Fred Gordin
  • Sean Emery
  • Gerd Fätkenheuer
  • Jean-Michel Molina
  • Robin Wood
  • James D Neaton
  • INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group ( Lars Mathiesen, members)
View graph of relations
Original languageEnglish
JournalHIV Medicine
Volume16 Suppl 1
Pages (from-to)1-9
Number of pages9
ISSN1464-2662
DOIs
Publication statusPublished - Apr 2015

ID: 45731738